CRIOKEEP: device for the cryogenic storage, transport and dosing of therapeutic products
CRIOKEEP
Customised health
The effectiveness and cost of using advanced therapeutic products is currently limited by the need to use different consumables to comply with the protocols (storage, transport and dosage for the patient).
CRIOKEEP proposes a solution that includes in a single consumable devices the functions of cryogenic storage, transport and dosing of a therapeutic product to the patient, while reducing the number of processes. The risks of contamination, sample loss and loss of traceability with the counter-sample are thus eliminated…
The project – focused on its use in advanced therapies of customised medicine (cellular, gene….) – is based on a product that has been developed, tested and patented by Leartiker in collaboration with CUN, with the ensuing competitive advantage.
Tagline: Device for the cryogenic storage, transport and dosing of therapeutic products.
Financing needs:
CEO contracting: €65,000 a year
Manufacturing process development: €45,000 (excluding Leartiker support)
Certification costs (CE marking): €120,000 (excluding Leartiker and CUN support)
Costs of deploying commercial/productive action plan: €22,000 (excluding Leartiker support)
Costs of the stage of increasing product range (mould): €23,000 (excluding Leartiker support).
Phase 1: Cellular therapy and regenerative medicine units (Hospitals)
Phase 2: Medical distributors
Oops! We could not locate your form.
Related news
SAFEMOB: artificial intelligence for safer and more efficient public transport
Basque Tek Ventures backs this project that integrates AI in passenger vehicles to anticipate incidents and improve the travel experience
RECONNECT: spinal cord reconnection for people with spinal cord injuries
Basque Tek Ventures promotes this disruptive project that seeks to restore lost functions through state-of-the-art biocompatible implants
ILARGIA: AI-based platform for de novo protein design and optimisation
The project, powered by Basque Tek Ventures, promotes advanced biotechnological solutions for laboratories, academia and companies through an end-to-end approach
BEGI: on-chip 3D vision processor with back-end AI systems to enable neuromorphic DVS sensors
Basque Tek Ventures promotes this initiative to offer a new generation of three-dimensional perception in real time, more efficient and sustainable
Prospect Biotech: real-time analysis of cell cultures using light
Basque Tek Ventures is backing this project that offers an optic solution to develop and monitor advanced therapies.
Makby: 3D bioprinting software for regenerative medicine
Basque Tek Ventures is backing this initiative that will revolutionise the field of artificial biological tissues.
Konbus+: Controlled temperature and high velocity thermal spray systems
The initiative, coming under Basque Tek Ventures, provides high value-added coatings in extreme conditions in a cost-effective manner.
K-ALMA: Generative AI for reliable software tests
Basque Tek Ventures is backing this project that automates the code validations by reducing their high certification cost.
INTELLIWELD: assessment of weld quality
Basque Tek Ventures supports this initiative offering an integrated system to analyse and control process and product in welding systems.
FATRIXGEL: universal biomaterial for 3D cell cultures
The project, coming under Basque Tek Ventures, will revolutionise the generation of tissues to be used to research pharmaceutical and biotechnological therapies.